机译:使用改性血栓抑制试剂的实时检测和分化直接口服抗凝血剂(Rivaroxaban和Dabigatran)
Ludwig Maximilians Univ Munchen Dept Anaesthesiol Univ Hosp Marchioninistr 15 D-81377 Munich;
Ludwig Maximilians Univ Munchen Dept Anaesthesiol Univ Hosp Marchioninistr 15 D-81377 Munich;
Ludwig Maximilians Univ Munchen Dept Anaesthesiol Univ Hosp Marchioninistr 15 D-81377 Munich;
Ludwig Maximilians Univ Munchen Dept Anaesthesiol Univ Hosp Marchioninistr 15 D-81377 Munich;
Ludwig Maximilians Univ Munchen Dept Neurol Univ Hosp Munich Germany;
Ludwig Maximilians Univ Munchen Dept Neurol Univ Hosp Munich Germany;
TEM Innovat Munich Germany;
Ludwig Maximilians Univ Munchen Dept Anaesthesiol Univ Hosp Marchioninistr 15 D-81377 Munich;
Ludwig Maximilians Univ Munchen Dept Anaesthesiol Univ Hosp Marchioninistr 15 D-81377 Munich;
Thromboelastometry; Direct oral anticoagulants; Rivaroxaban; Dabigatran;
机译:使用改性血栓抑制试剂的实时检测和分化直接口服抗凝血剂(Rivaroxaban和Dabigatran)
机译:直接口服抗凝血剂Rivaroxaban和Dabigatran不抑制小鼠中人乳腺癌的原位生长和转移
机译:一种简单而快速的HPLC-MS / MS / MS方法,用于同时测定人类等离子体中的达哌沙班,Dabigatran,罗昔芬巴坎
机译:RecoSdoc-MTEV的开发和评估改善静脉血栓栓塞术治疗直接口服抗凝药物的质量。
机译:从精密医学到直接口服抗凝剂的抗凝剂导航安全性
机译:使用凝血酶生成试验评估直接口服抗凝剂达比加群利伐沙班和阿哌沙班在健康男性志愿者中的作用
机译:超高效液相色谱-串联质谱法(UPLC-MS / MS)和凝血测定法测定达比加群,利伐沙班和阿哌沙班的含量,用于监测新型直接口服抗凝剂的治疗